Actelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance Report
Summary
Actelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Actelion Pharmaceuticals Ltd. (Actelion or 'the company'), a subsidiary of Johnson & Johnson, is a biopharmaceutical company focused on the discovery, development and commercialization of low molecular weight drugs to address high unmet medical needs. The company's business is primarily focused on discovery, development and commercialization of innovative medicines for unmet medical needs. It offers variety of drugs for the treatment of cardiovascular disorders, infectious diseases, cancer, central nervous system disorders, and immunological disorders. The company has its operations in North and South America, Europe and Asia Pacific. The company is headquartered in Allschwil, Switzerland.
Scope
Reasons to Buy
Summary
Actelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Actelion Pharmaceuticals Ltd. (Actelion or 'the company'), a subsidiary of Johnson & Johnson, is a biopharmaceutical company focused on the discovery, development and commercialization of low molecular weight drugs to address high unmet medical needs. The company's business is primarily focused on discovery, development and commercialization of innovative medicines for unmet medical needs. It offers variety of drugs for the treatment of cardiovascular disorders, infectious diseases, cancer, central nervous system disorders, and immunological disorders. The company has its operations in North and South America, Europe and Asia Pacific. The company is headquartered in Allschwil, Switzerland.
Scope
- Detailed information on Actelion Pharmaceuticals Ltd required for business and competitor intelligence needs.
- A study of the major internal and external factors affecting Actelion Pharmaceuticals Ltd in the form of a SWOT analysis.
- An in-depth view of the business model of Actelion Pharmaceuticals Ltd including a breakdown and examination of key business segments.
- Intelligence on Actelion Pharmaceuticals Ltd's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors.
- News about Actelion Pharmaceuticals Ltd, such as business expansion, restructuring, and contract wins.
- Large number of easy-to-grasp charts and graphs that present important data and key trends.
Reasons to Buy
- Gain an understanding of Actelion Pharmaceuticals Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Actelion Pharmaceuticals Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Actelion Pharmaceuticals Ltd's business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Actelion Pharmaceuticals Ltd: Company Overview
- Actelion Pharmaceuticals Ltd: Overview and Key Facts
- Actelion Pharmaceuticals Ltd: Overview
- Actelion Pharmaceuticals Ltd: Key Facts
- Actelion Pharmaceuticals Ltd: Key Employees
- Actelion Pharmaceuticals Ltd: Key Employee Biographies
- Actelion Pharmaceuticals Ltd: Major Products and Services
- Actelion Pharmaceuticals Ltd: Company History
- Actelion Pharmaceuticals Ltd: Locations and Subsidiaries
- Actelion Pharmaceuticals Ltd: Key Competitors
- Actelion Pharmaceuticals Ltd: Company Analysis
- Actelion Pharmaceuticals Ltd: Business Description
- Actelion Pharmaceuticals Ltd: SWOT Analysis
- Actelion Pharmaceuticals Ltd: SWOT Overview
- Actelion Pharmaceuticals Ltd: Strengths
- Actelion Pharmaceuticals Ltd: Weaknesses
- Actelion Pharmaceuticals Ltd: Opportunities
- Actelion Pharmaceuticals Ltd: Threats
- Actelion Pharmaceuticals Ltd: Corporate Financial Deals Activity
- Actelion Pharmaceuticals Ltd: Financial Deals Overview
- Actelion Pharmaceuticals Ltd: Targets and Partners
- Actelion Pharmaceuticals Ltd: Top Deals 2016 - 2020YTD*
- Actelion Pharmaceuticals Ltd: Advisors
- Actelion Pharmaceuticals Ltd: Top Legal Advisors
- Actelion Pharmaceuticals Ltd: Top Financial Advisors
- Actelion Pharmaceuticals Ltd: Partnership
- Actelion Pharmaceuticals Ltd: Divestments
- Actelion Pharmaceuticals Ltd: Private Equity and Ownership
- Actelion Pharmaceuticals Ltd: Recent Developments
- Actelion Pharmaceuticals Ltd: News and Events Summary
- Actelion Pharmaceuticals Ltd: Business Expansion
- Actelion Pharmaceuticals Ltd: Corporate Governance
- Actelion Pharmaceuticals Ltd: Financial Performance
- Actelion Pharmaceuticals Ltd: Regulatory and Legal Events
- Actelion Pharmaceuticals Ltd: Research & Development
- Actelion Pharmaceuticals Ltd: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- About the Author
List of Tables
Table 1: Actelion Pharmaceuticals Ltd: Key Facts
Table 2: Actelion Pharmaceuticals Ltd: Key Employees
Table 3: Actelion Pharmaceuticals Ltd: Company History
Table 4: Actelion Pharmaceuticals Ltd: Locations and Subsidiaries
Table 5: Actelion Pharmaceuticals Ltd: Key Competitors
Table 6: Actelion Pharmaceuticals Ltd: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Actelion Pharmaceuticals Ltd: Targets and Partners
Table 8: Actelion Pharmaceuticals Ltd: Top Deals 2016 - 2020YTD*
Table 9: Actelion Pharmaceuticals Ltd: Legal Advisor Ranking by Value (US$m)
Table 10: Actelion Pharmaceuticals Ltd: Financial Advisor Ranking by Value (US$m)
Table 11: Actelion Pharmaceuticals Ltd: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 12: Actelion Pharmaceuticals Ltd: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 13: Actelion Pharmaceuticals Ltd: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 14: Actelion Pharmaceuticals Ltd: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 15: Actelion Pharmaceuticals Ltd: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 16: Actelion Pharmaceuticals Ltd: News and Events Summary
Table 17: Actelion Pharmaceuticals Ltd: Business Expansion
Table 18: Actelion Pharmaceuticals Ltd: Corporate Governance
Table 19: Actelion Pharmaceuticals Ltd: Financial Performance
Table 20: Actelion Pharmaceuticals Ltd: Regulatory and Legal Events
Table 21: Actelion Pharmaceuticals Ltd: Research & Development
Table 22: Actelion Pharmaceuticals Ltd: Strategy and Operations
List of Figures
Figure 1: Actelion Pharmaceuticals Ltd: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Figure 2: Actelion Pharmaceuticals Ltd: Partnership Volume and Value Trend (2016 - YTD*2020)
Figure 3: Actelion Pharmaceuticals Ltd: Partnership Trend by Deal Type (2016 - YTD*2020)
Figure 4: Actelion Pharmaceuticals Ltd: Divestments Volume and Value Trend (2016 - YTD*2020)
Figure 5: Actelion Pharmaceuticals Ltd: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Figure 6: Actelion Pharmaceuticals Ltd: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
